GlassScriptPhysician profile
Brett R Smith
NPI 1912987306
$4,001.29
in general payments reported to CMS, 2019-2025
14 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $292 · 2021: $2,908 · 2022: $157 · 2023: $134 · 2024: $13.32 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $2,750.00 | 2021 | |
| Pacira Therapeutics, INC. | $468.42 | 2019-2021 | |
| Stryker Corporation | $237.46 | 2025 | Mako |
| Depuy Synthes Sales INC. | $135.68 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $94.77 | 2022-2025 | Iovera, Exparel |
| Zimmer Biomet Holdings, INC. | $75.00 | 2023 | |
| Gemini Mountain Medical, LLC | $62.07 | 2020 | |
| Sanofi-Aventis U.S. LLC | $43.68 | 2019 | |
| Nalu Medical, INC. | $42.44 | 2025 | Nalu Neurostimulation System |
| Exactech, INC. | $29.93 | 2019 | |
| Bioventus LLC | $17.49 | 2023 | Durolane |
| Smith+Nephew, INC. | $17.09 | 2019 | |
| Mayne Pharma Commercial LLC | $13.94 | 2020 | |
| Abbott Laboratories | $13.32 | 2024 | Prodigy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.